Noticias de KPTI_US
Noticias del mercado
Últimas noticias sobre KPTI_US — 136 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Karyopharm Earnings Call: Trial Wins, Cash Questions
Karyopharm Therapeutics Inc (KPTI) Q1 2026 Earnings Call Highlig
Karyopharm Therapeutics Inc. Q1 2026 Earnings Call Summary
Karyopharm Therapeutics (KPTI) Reports Strong Q1 Earnings, Beats Expectations
Affinity Asset Advisors reports 2.07M shares in Karyopharm (KPTI)
Karyopharm Therapeutics Inc. Q1 2026 Financial Results and SEC 10-Q Filing Highlights
Karyopharm Therapeutics Q1 Earnings Call Highlights
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer
Karyopharm Therapeutics Releases Q1 2026 Financial Results
Karyopharm Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript
Karyopharm Therapeutics Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KPTI) 2026-05-14
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates
Karyopharm Therapeutics stock (US48576U1060): Q1 revenue beats estimates, trial enrollment complete
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Posts Q1 Beat and Highlights ASCO Presentation, Shares Surge 7%
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
Is Karyopharm Therapeutics (KPTI) Overvalued After Q1 2026 Earni
Karyopharm Therapeutics Inc. 1Q 2026: Revenue $35.1M, EPS $(1.24) — 10-Q Summary
Karyopharm (NASDAQ: KPTI) posts Q1 loss and warns on going concern
Karyopharm Therapeutics: Q1 Earnings Snapshot
Karyopharm (NASDAQ: KPTI) posts Q1 2026 growth and key trial updates
Página 1 de 7
